CAPR FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

Rosen Law Firm is reminding investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who purchased securities between December 17, 2025 and July 26, 2026 of the September 28, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Capricor made materially false statements regarding changes to its statistical analysis plan for Deramiocel without FDA approval, creating significant regulatory risk for the cell therapy's approval for treating Duchenne muscular dystrophy.